Manufacturer:
Novartis
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Approved Indication:
prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant, in combination with other immunosuppressants
Conditions:
- Solid Organ Transplant
Therapeutic Area:
- Nephrology